Method for determining active concentrations and/or kinetic interaction constants in complex biological samples by means of surface plasmon resonance
AssigneesUniversite De Bordeaux, Centre Hospitalier Universitaire De Bordeaux, Centre National De La Recherche Scientifique, Inserm (Institut National De La Sante Et De La Recherche Medicale)
InventorsJonathan Visentin, Carmelo Di Primo, Jean-Luc Taupin
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for determining active concentrations of an analyte and optionally kinetic constants for the interaction of the analyte with a ligand in complex biological samples by means of surface plasmon resonance comprising the use of an auto-blank.
Claims11
A method for determining, by surface plasmon resonance in complex biological samples, active concentrations of an analyte and optionally kinetic constants of interaction of the analyte with a ligand, comprising
- providing a surface plasmon resonance chip on which a capture agent specific to a ligand of the analyte is immobilized;
- capture, by the capture agent, of a control ligand that does not bind the analyte to be tested;
- passage of the sample over the chip, injected at a determined flow rate for a determined duration and obtaining a sensorgram for the control ligand;
- regeneration of the surface to remove the captured control ligand from the capture agent;
- capture, by the capture agent, of a ligand that binds the analyte to be tested;
- passage of the sample over the chip, injected at the same determined flow rate for the same determined duration and obtaining a sensorgram for the analyte;
- subtraction of the sensorgram obtained with the control ligand from the sensorgram obtained with the ligand that binds the analyte to be tested;
- and
- calculation of the active concentration of the analyte and optionally kinetic constants of interaction of the analyte with the ligand,
- and characterized in that the control ligand and the ligand that binds the analyte to be tested are of a similar mass and the control ligand and the ligand that binds the analyte to be tested are captured in equivalent amounts by the capture agent.
Dependencies are inferred from the claim text.